Kidney Failure in Cats Stages: Complete Guide to IRIS Classification and What Each Stage Means

Introduction

Kidney failure in cats is classified into four stages using the IRIS (International Renal Interest Society) staging system, based primarily on blood creatinine levels, SDMA concentrations, protein loss in urine, and blood pressure. Each stage reflects a progressive decline in kidney function and guides veterinarians in selecting appropriate treatments, dietary changes, and monitoring schedules.

This guide covers the complete IRIS staging framework for feline chronic kidney disease, the symptoms that appear at each stage, how veterinarians diagnose and classify the condition, and what cat owners can expect in terms of prognosis and management. It is written for cat owners concerned about kidney disease in cats-particularly those with senior and geriatric cats or those navigating a recent CKD diagnosis. Understanding which stage your cat falls into directly shapes treatment decisions and quality of life planning, making this knowledge essential rather than academic.

The IRIS staging system classifies CKD into four stages, ranging from early kidney damage with no visible symptoms to end stage kidney failure with severe systemic illness. Cats diagnosed at earlier stages consistently have better outcomes, with early diagnosis improving prognosis and quality of life significantly.

By reading this guide, you will:

• Understand what each of the four IRIS stages means in measurable terms
• Recognize the clinical signs associated with each stage of kidney failure
• Learn which diagnostic tests veterinarians use and how to interpret key values
• Know the prognosis expectations and treatment approaches for each stage
• Identify when to seek veterinary help and how to track disease progression

Understanding Kidney Failure in Cats

Chronic kidney disease is a progressive, irreversible condition in which a cat’s kidneys gradually lose their ability to perform essential functions. Healthy kidneys filter metabolic waste products like creatinine and blood urea nitrogen from the bloodstream, regulate blood pressure, maintain electrolyte and fluid balance, support red blood cell production through erythropoietin, and activate vitamin D. When kidney tissue is damaged and nephrons-the functional filtering units-are permanently lost, these processes deteriorate over months to years.

For cat owners, understanding staging matters because it transforms a vague diagnosis into a concrete framework. Staging tells you how much kidney function remains, what symptoms to expect, and which interventions can make the biggest difference at each point in the disease.

Types of Kidney Disease

Kidney failure in cats is usually categorized as Acute Kidney Injury (AKI) or Chronic Kidney Disease (CKD). These two conditions differ fundamentally in onset, reversibility, and management.

Acute Kidney Injury (AKI) can result from sudden events such as toxin ingestion or severe dehydration, urinary tract obstruction, or certain infections. It develops over hours to days and may be partially or fully reversible with aggressive treatment. Avoid toxic plants like lilies to prevent kidney failure-lily ingestion is one of the most common causes of acute renal failure in cats. Seizures can occur in cats with acute kidney failure due to the rapid buildup of uremic toxins.

Chronic kidney disease, by contrast, develops gradually as kidney tissue is replaced by scar tissue. Chronic Kidney Disease (CKD) is often caused by age-related degeneration and genetic predisposition, though underlying conditions like periodontal disease, urinary tract infections, and congenital abnormalities can contribute. Because the nephron loss in CKD is irreversible, the IRIS staging system applies specifically to chronic cases-not to acute or acute-on-chronic kidney injury. Staging requires that the cat be stable and well hydrated, ensuring the measurements reflect true chronic kidney dysfunction rather than temporary changes.

The IRIS Classification System

The International Renal Interest Society is a global veterinary nonprofit that publishes standardized guidelines for diagnosing, staging, and treating CKD in cats and dogs. Veterinarians worldwide use IRIS staging because it creates a common language for assessing disease severity, comparing treatment outcomes, and communicating prognosis to owners.

The system relies on three key measurements:

• Blood creatinine and SDMA levels: Creatinine is a waste product filtered by the kidneys, and its concentration in the blood rises as kidney function declines. SDMA (symmetric dimethylarginine) is a newer biomarker that is less influenced by muscle mass and can detect decreased kidney function earlier than creatinine alone. SDMA levels rise earlier than creatinine in kidney dysfunction, making it particularly valuable for identifying early stages in older cats with reduced muscle mass.
• Urine protein levels: Measured via the urine protein-to-creatinine ratio (UPC), proteinuria indicates glomerular damage and predicts faster disease progression.
• Systemic blood pressure: High blood pressure both results from and accelerates kidney damage, and blood pressure measurement is crucial in diagnosing CKD. Systolic readings above 160 mmHg carry moderate to high risk for target organ damage.

These measurements determine not only the primary stage but also substages that refine prognosis and treatment. With this framework established, the following section breaks down exactly what each stage means for your cat.

The Four Stages of Kidney Failure in Cats

The four IRIS stages represent a continuum of progressive kidney function loss, from subclinical damage detectable only through screening to severe end-stage disease with systemic complications. Veterinarians often track multiple parameters over time to monitor and stage CKD accurately, requiring at least two blood tests showing consistent creatinine values (within 10–20% variation) over two to four weeks before assigning a stage.

Each stage below includes the blood values that define it, the clinical signs you may observe, the degree of remaining kidney function, and what to expect in terms of prognosis and management.

Stage 1: Early Kidney Damage

Blood values: Creatinine remains below 1.6 mg/dL (normal range), and SDMA is below 18 µg/dL. Stage 1 shows no clinical signs or azotemia-meaning nitrogenous waste products have not accumulated enough to elevate blood values. However, other abnormalities may be present: proteinuria on urine tests, abnormal kidney appearance on imaging, reduced ability to concentrate urine effectively, or a persistently rising creatinine trend that remains within the reference range.

Clinical signs: Usually no visible symptoms. Most cats in Stage 1 appear completely healthy, which is precisely why this stage is so frequently missed. Cats hide illness instinctively, and without routine screening, early kidney damage goes undetected.

Kidney function: Minimal loss. The remaining nephrons compensate effectively through hypertrophy, maintaining adequate filtration. Over 75% kidney function loss is needed for azotemia to appear, which means Stage 1 cats may have already lost a significant portion of nephrons without any bloodwork abnormality.

Prognosis and management: The prognosis at Stage 1 is the most favorable of any stage. Many cats live multiple years without clinical progression. Treatment focuses on identifying and mitigating risk factors-ensuring adequate hydration, controlling blood pressure if elevated, addressing proteinuria, and establishing a monitoring baseline. Regular check-ups can catch kidney disease early, and cats over seven should have annual kidney screenings. SDMA testing detects kidney function loss earlier than creatinine, making it an essential component of wellness panels for older cats.

Stage 2: Mild Kidney Failure

Blood values: Creatinine is mildly elevated at 1.6–2.8 mg/dL, with SDMA ranging from 18 to 25 µg/dL. Stage 2 has decreased kidney function with azotemia present, marking the first time waste products accumulate measurably in the cat’s blood. Urine specific gravity begins to decline (around 1.030 compared to ~1.050 in healthy cats), reflecting the kidneys’ diminishing ability to concentrate urine. UPC ratio may be borderline proteinuric (0.2–0.4).

Clinical signs: Increased thirst and urination are early signs of kidney failure and may become noticeable at this stage. Some cats show subtle weight loss or a dull coat. However, many cats with CKD at Stage 2 still appear relatively well, and owners may attribute changes to normal aging.

Kidney function: Approximately 33–67% of function remaining. Compensatory mechanisms are still active, but kidney function declines progressively, and the kidneys lose reserve capacity.

Treatment and life expectancy: This is the stage where intervention has the greatest impact on long-term outcomes. A prescription kidney diet restricted in protein and phosphorus becomes a cornerstone of management-cats with CKD fed a renal support diet live twice as long as those on standard food. Phosphorus binders, hydration management, and blood pressure medication if hypertension is detected are key interventions. Cats diagnosed at IRIS Stage 2 CKD live 2–3 years on average, with some studies showing median survival of approximately 1,151 days (~3.2 years) for cats in the upper range of Stage 2 when properly managed. Routine blood tests help monitor kidney health in cats at this stage, typically every three to six months.

Stage 3: Moderate Kidney Failure

Blood values: Creatinine rises to 2.9–5.0 mg/dL, and SDMA reaches 26–38 µg/dL. Stage 3 indicates worsening azotemia and clinical signs appear more consistently. Phosphorus levels often become elevated, and poorly concentrated urine (USG around 1.020) with dilute urine output is common. UPC typically exceeds 0.4, indicating significant proteinuria. Higher phosphorus levels at diagnosis correlate with shorter survival.

Clinical signs: This is when disease progresses to the point that owners clearly notice changes. Weight loss and lethargy are common symptoms in kidney failure cats at this stage. Vomiting and decreased appetite often occur in cats with kidney failure, and poor appetite may become a persistent concern. Anemia can develop in advanced CKD due to reduced erythropoietin production by damaged kidneys, which further contributes to weakness and fatigue. Some cats develop a hunched posture reflecting discomfort.

Kidney function: Approximately 15–33% of function remaining. The kidneys can no longer adequately compensate, and metabolic complications including acidosis and secondary hyperparathyroidism may develop.

Active management: CKD treatment at Stage 3 requires intensified intervention. In addition to a strict kidney diet, affected cats may need phosphorus binders, anti nausea medications to manage gastrointestinal symptoms, potassium supplementation for electrolyte imbalances, and appetite stimulants like mirtazapine. Cats with CKD may need appetite stimulants like mirtazapine to maintain adequate caloric intake. Blood pressure medication becomes more critical if hypertension is present. Cats with CKD may require subcutaneous fluids for hydration, administered at home by trained owners. Median survival at Stage 3 is approximately 778 days (~2.1 years), though individual variation is substantial depending on how aggressively complications are managed.

Stage 4: Severe End-Stage Kidney Failure

Blood values: Creatinine exceeds 5.0 mg/dL (often reaching 6.9 mg/dL or higher), and SDMA is above 38 µg/dL. Stage 4 is end stage renal failure with severe symptoms across virtually every measured parameter. Blood urea nitrogen is markedly elevated, and multiple electrolyte, acid-base, and fluid disturbances are present simultaneously.

Clinical signs: Cats may develop an ammonia-like odor to their breath due to kidney failure-a hallmark of uremic syndrome. Severe nausea, vomiting, oral ulcers, profound weight loss, muscle mass depletion, and dehydration dominate the clinical picture. Uremic toxins accumulate throughout the body, affecting gastrointestinal, neurological, and cardiovascular systems. The cat’s health deteriorates noticeably, and quality of life becomes a central concern.

Kidney function: Less than 15% of function remaining, often under 10%. Nearly all compensatory capacity is exhausted.

Comfort care and difficult decisions: Treatment focuses on palliative and supportive care. Subcutaneous fluids, anti nausea medications, pain management, and nutritional support (including wet food to maximize fluid intake) form the basis of care. Hemodialysis can improve quality of life but is expensive and available only at specialized facilities. Cats in Stage 4 CKD survive less than 6 months on average, and many owners face decisions about euthanasia when suffering outweighs the benefits of continued treatment. Cats with CKD can live comfortably for years with proper management when caught early-but by Stage 4, the focus shifts firmly to comfort rather than cure.

How Veterinarians Diagnose and Stage Kidney Disease

With a clear understanding of what each stage represents, the next step is understanding how veterinarians arrive at a stage assignment. The diagnostic process combines multiple tests, repeated over time, to build an accurate picture of kidney health and disease severity.

Essential Diagnostic Tests

Blood work forms the foundation of CKD diagnosis. Blood tests measure creatinine and blood urea nitrogen levels, providing the primary staging metrics. SDMA is increasingly included in standard panels because it detects kidney dysfunction earlier and is less affected by muscle mass-critical for accurately evaluating kidney function in thin or geriatric cats. Phosphorus, calcium, and electrolyte panels identify metabolic complications. A complete blood count (CBC) assesses for non-regenerative anemia, which reflects reduced erythropoietin production by damaged kidney tissue and diminished stimulation of bone marrow. You can learn more about interpreting these values in this guide to cat blood test results explained.

Urinalysis assesses urine specific gravity and protein levels. Urine specific gravity reveals how well the kidneys can concentrate urine-healthy cats typically achieve USG above 1.035, while CKD cats produce progressively more dilute urine as the disease progresses. UPC ratio quantifies proteinuria: values below 0.2 are non-proteinuric, 0.2–0.4 borderline, and above 0.4 proteinuric. Urine samples should also be evaluated for signs of urinary tract infections or abnormal sediment.

Blood pressure measurement identifies hypertension, a common complication that both results from and accelerates renal disease. Systolic readings are categorized as: below 150 mmHg (minimal risk), 150–159 (low risk), 160–179 (moderate risk), and 180 mmHg or above (high risk for target organ damage). Controlling blood pressure is essential to slow progression and protect other organs.

Imaging studies like ultrasound help evaluate kidney structure, assessing kidney size, cortical thickness, and echogenicity. In advanced feline chronic kidney disease, kidneys appear small with thinned cortex and irregular outlines. Additional tests such as iohexol clearance GFR measurement may be used in suspected early disease to evaluate kidney function when blood values remain normal.

Staging Process and Timeline

The staging process follows a structured sequence:

1. Initial blood work and urinalysis identify potential CKD and provide preliminary kidney values
2. Confirmatory testing repeats creatinine and SDMA measurements two to four weeks later under stable, well-hydrated conditions to confirm consistency (variation must be less than 10–20%)
3. Sub-staging assigns proteinuria classification (UPC) and blood pressure risk category once the primary stage is determined
4. Ongoing monitoring adjusts the stage as the disease progresses-Stage 1–2 cats may need re-evaluation every three to six months, while Stage 3–4 cats require more frequent checks

CompanAIn’s platform can help track lab results and trends over time, providing visual timelines that reveal whether creatinine, SDMA, or UPC values are trending upward and alerting when key markers cross staging thresholds. This kind of trend monitoring is particularly valuable because single measurements can be misleading-it is the trajectory that tells the true story.

Hydration management is crucial as dehydration can exacerbate kidney disease in cats and artificially elevate creatinine readings, so veterinarians emphasize that staging tests must be performed when the cat is well hydrated.

Understanding Your Cat's Lab Results

The following table summarizes normal versus abnormal ranges for the key markers used in IRIS staging:

When reviewing your cat’s results-whether through your veterinarian or a tool like CompanAIn’s lab interpretation features-keep in mind that muscle mass influences creatinine readings. A thin or elderly cat may show artificially low creatinine despite significant kidney dysfunction, which is exactly why SDMA provides a valuable complementary measurement.

Treatment goals for CKD include slowing progression and managing metabolic toxins, and understanding your cat’s specific values helps you and your veterinarian calibrate the right approach. Key questions to ask include: “Was my cat well hydrated when these samples were taken?” “What is my cat’s SDMA trend over time?” “Is there proteinuria, and what is the UPC value?” “What is the blood pressure reading?”

Common Staging Challenges and Solutions

Even with standardized criteria, diagnosing and staging feline CKD involves real-world complexities that cat owners should understand.

Early Stage Detection Difficulties

Problem: Many cats with Stage 1 CKD go undiagnosed because they show no clinical signs, and creatinine stays normal until approximately 75% of kidney function is lost. Cats instinctively mask illness, and owners often dismiss subtle increases in water intake as unremarkable.

Solution: Schedule annual wellness screenings for cats over seven, including SDMA alongside standard bloodwork. Trending lab values over time-rather than looking at single snapshots-reveals subtle declines before they cross clinical thresholds. Early detection transforms prognosis: catching feline CKD at Stage 1 or early Stage 2 opens the widest window for intervention. An AI-powered symptom checker can also help identify subtle behavioral changes worth discussing with your veterinarian.

Conflicting Test Results

Problem: Sometimes creatinine appears normal while SDMA is elevated, or proteinuria is present without other abnormalities. Dehydration, recent high-protein meals, concurrent infections, or significant muscle mass loss can distort individual markers, creating confusion about the true stage.

Solution: No single test should be interpreted in isolation. Comprehensive evaluation integrates creatinine, SDMA, UPC, imaging, urine specific gravity, and blood pressure into a complete picture. When results conflict, repeat testing under controlled conditions-fasting, well-hydrated-and look at trends across multiple visits. A veterinary second opinion can provide additional perspective when staging feels uncertain.

Managing Progression Between Stages

Problem: After diagnosis, many cat owners experience significant anxiety about when-not if-the disease will advance to the next stage. This can lead to hypervigilance or, conversely, avoidance of veterinary visits.

Solution: Focus on quality of life metrics and proactive monitoring rather than fixating on stage numbers. Risk factors that accelerate progression include uncontrolled high blood pressure, persistent proteinuria, elevated phosphorus, dehydration, and inappropriate diet. Addressing these factors with proper treatment-renal diets, blood pressure medication, phosphorus binders, and consistent hydration through subcutaneous fluids or increased wet food intake-gives the best chance of slowing progression. Ckd cats whose owners engage in structured monitoring and early intervention consistently have better outcomes. CompanAIn’s tracking tools can provide objective trend data that helps manage both the disease and the anxiety.

Conclusion and Next Steps

Understanding the stages of kidney failure in cats transforms a frightening diagnosis into a framework for action. Each IRIS stage carries specific implications for treatment intensity, monitoring frequency, and prognosis-and knowing where your cat stands allows you to make informed decisions alongside your veterinarian. Most cats with CKD, particularly those diagnosed at early stages, can maintain good quality of life for extended periods with appropriate management.

Take these steps based on your situation:

1. If your cat is over seven with no diagnosis: Schedule an annual wellness screening that includes creatinine, SDMA, and urinalysis to establish baseline kidney values
2. If your cat has been diagnosed with CKD: Confirm the IRIS stage with your veterinarian, discuss sub-staging for proteinuria and blood pressure, and establish a monitoring schedule
3. If you’re managing an existing diagnosis: Track lab trends systematically, ensure your cat is on an appropriate prescription kidney diet, and address risk factors like dehydration and hypertension proactively

For ongoing monitoring, CompanAIn’s health tracking tools can help you visualize lab trends, understand what your cat’s kidney values mean, and identify changes that warrant a veterinary visit before they become emergencies.

Related topics worth exploring include stage-specific treatment protocols, quality of life assessment tools for cats with renal failure, and nutritional strategies for managing feline kidney disease at each stage.

Additional Resources

• CompanAIn’s kidney disease tracking and lab interpretation guides for monitoring your cat’s kidney health over time
• The IRIS staging system guidelines for the complete clinical staging criteria and treatment recommendations
• Quality of life assessment scales designed specifically for cats with chronic kidney disease
• Emergency signs requiring immediate veterinary attention: sudden refusal to eat, uncontrolled vomiting, seizures, extreme lethargy, or collapse